Process for the manufacture of HMG-CoA reductase inhibitors

Details Process for the manufacture of HMG-CoA reductase inhibitors Process for the manufacture of HMG-CoA reductase inhibitors

2008-05-13

2008-05-13

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S490000

Reexamination Certificate

active

10502177

ABSTRACT:
The invention relates to a process for the manufacture of a compound of formulaor a salt, especially a pharmaceutically acceptable salt with a base, thereof or a lactone thereof wherein the elementrepresents —CH2—CH2— or —CH═CH— and R represents a cyclic residue.

REFERENCES:
patent: 4650890 (1987-03-01), Jewell et al.
patent: 5034399 (1991-07-01), Hübsch et al.
patent: 5049577 (1991-09-01), Varma et al.
patent: 5354772 (1994-10-01), Kathawala
patent: 5856336 (1999-01-01), Fujikawa et al.
patent: 6528661 (2003-03-01), Niddam et al.
patent: 6835838 (2004-12-01), Chen et al.
patent: 6909003 (2005-06-01), Storz
patent: 6965031 (2005-11-01), Hara
patent: 7064209 (2006-06-01), Horiuchi et al.
patent: 0 304 063 (1989-02-01), None
patent: 0 340 007 (1989-11-01), None
patent: 0 520 406 (1992-12-01), None
Cohen and Khedouri, vol. 83, pp. 4228-4233.
Heathcock et al., “Total Synthesis and Biological Evaluation of Structural Analogues of Compactin and dihydromevinolin”,J Med Chem, vol. 30, No. 10, pp. 1858-1873 (1980).
Karanewsky, Malley and Gougoutas, “Practical Synthesis of an Enantiomerically Pure Synthon for the Preparation of Mevinic Acid Analogues”,J Org Chem, vol. 56, No. 11, pp. 3744-3747 (1991).
Matsumura, Hashiguchi, Ikariya and Noyori, “Asymmetric Transfer Hydrogenation of α,β-Acetylenic Ketones”,J Am Chem Soc, vol. 119, No. 37, pp. 8738-8739 (1997).
Ozegowski, Kunath and Schick, “Lipase-Catalyzed Asymmetric Alcoholysis of 3-Substituted Pentanedioic Anhydrides”,Liebigs Ann Chem, pp. 805-808 (1993).
Rosen, Wantanabe and Heathcock, “A Convenient Assay for the Optical Purity of Monmethyl 3-Hydroxypentanedioate”,J Org Chem, vol. 49, No. 19, pp. 3657-3659 (1984).
Suzuki et al., “First Systematic Chiral Syntheses of Two Pairs of Enantiomers with 3,5-Dihydroxyheptenoic Acid Chain, Associated with a Potent Synthetic Statin NK-104”,Bioorg Med Chem Lett, vol. 9, No. 20, pp. 2977-2982 (1999).
Theisen and Heathcock, “Improved Procedure for Preparation of Optically Active 3-Hydroxyglutarate Monoesters and 3-Hydroxy-5-oxoalkanoic Acids”,J Org Chem, vol. 53, No. 10, pp. 2374-2378 (1988).
Vries et al., “The Family Approach to the Resolution of Racemates”,Angew Chem Int Ed, vol. 37, No. 17, pp. 2349-2354 (1998).

Affiliated with

Also associated with

Rating

Process for the manufacture of HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the manufacture of HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the manufacture of HMG-CoA reductase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3959804